Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Bio-Techne (TECH) over the last 12 years, with Q4 2025 value amounting to $488.6 million.

  • Bio-Techne's Total Non-Current Liabilities fell 1583.94% to $488.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $488.6 million, marking a year-over-year decrease of 1583.94%. This contributed to the annual value of $612.0 million for FY2025, which is 158.91% down from last year.
  • As of Q4 2025, Bio-Techne's Total Non-Current Liabilities stood at $488.6 million, which was down 1583.94% from $536.5 million recorded in Q3 2025.
  • Bio-Techne's Total Non-Current Liabilities' 5-year high stood at $749.8 million during Q4 2023, with a 5-year trough of $488.6 million in Q4 2025.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $596.6 million (2021), whereas its average is $611.1 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 2454.22% in 2021, then surged by 4283.65% in 2023.
  • Over the past 5 years, Bio-Techne's Total Non-Current Liabilities (Quarter) stood at $590.1 million in 2021, then decreased by 11.04% to $525.0 million in 2022, then surged by 42.84% to $749.8 million in 2023, then dropped by 22.57% to $580.6 million in 2024, then fell by 15.84% to $488.6 million in 2025.
  • Its Total Non-Current Liabilities stands at $488.6 million for Q4 2025, versus $536.5 million for Q3 2025 and $612.0 million for Q2 2025.